IVD MEDICAL (01931): Tai Yang, previously an independent non-executive director, has been reassigned as an executive director.
Huajian Medical (01931) announced that Ms. Tai Yang has been appointed as an executive director of the company, transitioning from an independent non-executive director, effective from 2...
IVD MEDICAL (01931) Announcement: Ms. Tai Yang has been reassigned from an independent non-executive director to an executive director of the company, effective from October 20, 2025.
In light of the reassignment, the following changes to the Board of Directors took effect from October 20, 2025:
1. Ms. Tai Yang is no longer a member of the Remuneration Committee, and Mr. Zhang Jianlei has been appointed as a member of the Remuneration Committee; and
2. Ms. Tai Yang has resigned as the Chairman of the Nomination Committee, but will continue to serve as a member of the Nomination Committee, while Mr. Zhang Jianlei has been appointed as the Chairman of the Nomination Committee.
Related Articles

US Stock Market Move | Moderna (MRNA.US) rises more than 7% as data from two new mRNA vaccines show positive results

US Stock Market Move | ZK.US (Extremely Cool) Rises Over 4%, New ZK7X Officially Begins Pre-sale
.png)
US Stock Market Move | Gold concept stocks rise, spot gold surged over 2% intraday.
US Stock Market Move | Moderna (MRNA.US) rises more than 7% as data from two new mRNA vaccines show positive results

US Stock Market Move | ZK.US (Extremely Cool) Rises Over 4%, New ZK7X Officially Begins Pre-sale

US Stock Market Move | Gold concept stocks rise, spot gold surged over 2% intraday.
.png)
RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025